Literature DB >> 9633839

Epidemiology and risk assessment for ovarian cancer.

M Daly1, G I Obrams.   

Abstract

The incidence of ovarian cancer varies internationally with higher rates among women of North America and northern Europe. In the United States, there has been relatively little change in the incidence of ovarian cancer in recent decades. The incidence rate of ovarian cancer is highest among white and Hawaiian women, intermediate among African-American, Hispanic and Asian-American women, and lowest among Native American women. The most intensively studied risk factors have been family history, pregnancy history, and oral contraceptive use. Multiparity, lactation, oral contraceptive use, and tubal ligation/hysterectomy all decrease a woman's risk of ovarian cancer. One exposure that has been consistently associated with increased ovarian cancer risk is cosmetic talc applied to the perineum.

Entities:  

Mesh:

Year:  1998        PMID: 9633839

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  19 in total

1.  Racial differences in ovarian cancer risk.

Authors:  R B Ness; J A Grisso; J Klapper; R Vergona
Journal:  J Natl Med Assoc       Date:  2000-04       Impact factor: 1.798

Review 2.  Host factors and cancer progression: biobehavioral signaling pathways and interventions.

Authors:  Susan K Lutgendorf; Anil K Sood; Michael H Antoni
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

Review 3.  Biobehavioral influences on cancer progression.

Authors:  Erin S Costanzo; Anil K Sood; Susan K Lutgendorf
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

Review 4.  Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer.

Authors:  Ajay P Singh; Shantibhusan Senapati; Moorthy P Ponnusamy; Maneesh Jain; Subodh M Lele; John S Davis; Steven Remmenga; Surinder K Batra
Journal:  Lancet Oncol       Date:  2008-11       Impact factor: 41.316

5.  Effect of luteinizing hormone-induced prohibitin and matrix metalloproteinases on ovarian epithelial tumor cell proliferation.

Authors:  Yue Wang; Hong Liao; Holly C Zheng; Linmin Li; Lin Jia; Zhengbo Zhang; Wenxin Zheng
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

6.  CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins.

Authors:  R C Casey; A P Skubitz
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 7.  Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans.

Authors:  Atsuko Yoneda; Maria E Lendorf; John R Couchman; Hinke A B Multhaupt
Journal:  J Histochem Cytochem       Date:  2012-01       Impact factor: 2.479

8.  Luteinizing hormone compromises the in vivo anti-tumor effect of cisplatin on human epithelial ovarian cancer cells.

Authors:  Yan Huang; Yuqi Zhou; Lingfang Xia; Jia Tang; Hao Wen; Meiqin Zhang
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

9.  Human GM3 Synthase Attenuates Taxol-Triggered Apoptosis Associated with Downregulation of Caspase-3 in Ovarian Cancer Cells.

Authors:  Su Huang; Khadijeh Bijangi-Vishehsaraei; Mohammad Reza Saadatzadeh; Ahmad R Safa
Journal:  J Cancer Ther       Date:  2012-10

10.  Mucins in ovarian cancer diagnosis and therapy.

Authors:  Subhash C Chauhan; Deepak Kumar; Meena Jaggi
Journal:  J Ovarian Res       Date:  2009-12-24       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.